SMERUD MEDICAL RESEARCH INTERNATIONAL AS

0274 OSLO

Finances

Return on Equity

45,34 %

Current Ratio

1,24

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	63 456 000	37 974 000	42 293 000	38 235 000
Net Income	5 812 000	2 192 000	1 316 000	−1 513 000
Total Assets	47 467 000	28 828 000	29 801 000	31 751 000
Total Equity	12 818 000	7 007 000	1 375 000	1 254 000

Income (NOK)	2022	2021	2020	2019
Revenue	63 456 000	37 974 000	42 293 000	38 235 000
Expenditure	56 429 000	35 301 000	40 234 000	38 416 000
Operating Profit	7 026 000	2 672 000	2 060 000	−181 000
Financial Income	1 623 000	596 000	1 743 000	462 000
Financial Costs	2 837 000	1 076 000	954 000	1 101 000
Financial Balance	−1 214 000	−480 000	789 000	−639 000
Earnings Before Tax	5 812 000	2 192 000	2 849 000	−820 000
Tax	0	0	1 533 000	694 000
Net Income	5 812 000	2 192 000	1 316 000	−1 513 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	4 431 000	451 000	344 000	344 000
Total Current Assets	43 036 000	28 377 000	29 457 000	31 407 000
Total Assets	47 467 000	28 828 000	29 801 000	31 751 000
Total Retained Equity	7 146 000	1 334 000	−4 298 000	−4 418 000
Total Equity	12 818 000	7 007 000	1 375 000	1 254 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	34 649 000	21 822 000	28 426 000	30 497 000
Total Equity and Debt	47 467 000	28 828 000	29 801 000	31 751 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	63 056 000	34 567 000	28 751 000	25 887 000
Other Income	400 000	3 407 000	13 543 000	12 348 000
Revenue	63 456 000	37 974 000	42 293 000	38 235 000
Cost of Goods Sold	33 915 000	13 993 000	20 419 000	18 016 000
Salary Costs	14 721 000	12 075 000	13 393 000	11 882 000
Depreciation	30 000	0	0	0
Impairment	0	0	0	0
Expenditure	56 429 000	35 301 000	40 234 000	38 416 000
Operating Profit	7 026 000	2 672 000	2 060 000	−181 000
Financial Income	1 623 000	596 000	1 743 000	462 000
Financial Costs	2 837 000	1 076 000	954 000	1 101 000
Financial Balance	−1 214 000	−480 000	789 000	−639 000
Dividends	0	0	0	0
Net Income	5 812 000	2 192 000	1 316 000	−1 513 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	84 000	0	0	0
Total Tangible Assets	84 000	0	0	0
Total Fiancial Fixed Assets	4 347 000	451 000	344 000	344 000
Total Fixed Assets	4 431 000	451 000	344 000	344 000
Stock	0	0	0	0
Total Investments	5 000	0	0	0
Cash, Bank	12 497 000	3 351 000	10 091 000	12 995 000
Total Current Assets	43 036 000	28 377 000	29 457 000	31 407 000
Total Assets	47 467 000	28 828 000	29 801 000	31 751 000
Total Equity	12 818 000	7 007 000	1 375 000	1 254 000
Short-Term Group Debt	8 239 000	8 359 000	11 540 000	9 779 000
Total Long-Term Debt	0	0	0	0
Creditors	6 630 000	3 860 000	4 701 000	6 340 000
Unpaid Taxes	1 697 000	576 000	748 000	728 000
Dividends	0	0	0	0
Other Current Debt	18 083 000	9 026 000	10 241 000	12 352 000
Total Current Debt	34 649 000	21 822 000	28 426 000	30 497 000
Total Equity and Debt	47 467 000	28 828 000	29 801 000	31 751 000

Financial indicators	2022	2021	2020	2019
Return on Equity	45,34 %	31,28 %	95,71 %	−120,65 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	11,07 %	7,04 %	4,87 %	−0,47 %
Current Ratio	1,24	1,3	1,04	1,03
Quick Ratio	1,24	1,3	1,04	1,03
Equity Ratio	0,27	0,24	0,05	0,04
Gross Profit Margin	46,55 %	63,15 %	51,72 %	52,88 %